COSENZA, Maria
 Distribuzione geografica
Continente #
NA - Nord America 3.147
EU - Europa 1.132
AS - Asia 1.118
SA - Sud America 153
AF - Africa 47
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.602
Nazione #
US - Stati Uniti d'America 3.108
GB - Regno Unito 417
SG - Singapore 339
CN - Cina 298
IT - Italia 170
HK - Hong Kong 138
VN - Vietnam 131
SE - Svezia 129
BR - Brasile 106
DE - Germania 91
RU - Federazione Russa 61
FI - Finlandia 58
FR - Francia 54
TR - Turchia 53
UA - Ucraina 52
IN - India 27
CA - Canada 22
BG - Bulgaria 19
ID - Indonesia 18
KR - Corea 18
MA - Marocco 18
BD - Bangladesh 16
AR - Argentina 14
JP - Giappone 14
BE - Belgio 13
IQ - Iraq 13
NL - Olanda 13
ZA - Sudafrica 13
IE - Irlanda 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
EC - Ecuador 8
LT - Lituania 7
MX - Messico 7
PL - Polonia 7
MY - Malesia 6
PE - Perù 6
PK - Pakistan 6
EG - Egitto 5
ES - Italia 4
ET - Etiopia 4
LB - Libano 4
SA - Arabia Saudita 4
JO - Giordania 3
NI - Nicaragua 3
PH - Filippine 3
PT - Portogallo 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CH - Svizzera 2
CO - Colombia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
HR - Croazia 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
NO - Norvegia 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
BY - Bielorussia 1
CD - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.602
Città #
Ashburn 393
Fairfield 343
Southend 316
Santa Clara 242
Singapore 233
Woodbridge 231
Chandler 223
Houston 152
Hong Kong 136
Ann Arbor 126
San Jose 125
Seattle 118
Cambridge 113
Wilmington 95
Dearborn 88
Jacksonville 88
Nyköping 88
Beijing 72
Modena 58
London 57
Helsinki 40
Hefei 38
The Dalles 38
San Diego 37
Ho Chi Minh City 36
New York 36
Los Angeles 34
Council Bluffs 33
Hanoi 31
Izmir 28
Fremont 22
Princeton 21
Chicago 20
Eugene 20
Milan 19
Sofia 19
Jakarta 18
Seoul 18
Casablanca 17
Lauterbourg 17
Moscow 16
Shanghai 15
São Paulo 15
Brussels 13
Munich 13
Buffalo 12
Frankfurt am Main 12
Norwalk 11
Des Moines 10
Columbus 9
Dublin 9
San Giuliano Milanese 9
Tokyo 9
Falls Church 8
Johannesburg 8
Salt Lake City 8
Orem 7
Amsterdam 6
Bremen 6
Dallas 6
Dong Ket 6
Montreal 6
Redwood City 6
Toronto 6
Boardman 5
Changsha 5
Latina 5
Miami 5
Rome 5
San Francisco 5
Thái Nguyên 5
Addis Ababa 4
Atlanta 4
Baghdad 4
Belo Horizonte 4
Boston 4
Brasília 4
Charlotte 4
Chongqing 4
Da Nang 4
Haiphong 4
Nanjing 4
Parma 4
Phoenix 4
Poplar 4
Quito 4
Warsaw 4
Wuhan 4
Bologna 3
Campinas 3
Denver 3
Dhaka 3
Edinburgh 3
Handan 3
Hillsboro 3
Kunming 3
Lima 3
Montevideo 3
Naples 3
Ottawa 3
Totale 4.204
Nome #
Cell-penetrating CaCO3nanocrystals for improved transport of NVP-BEZ235 across membrane barrier in T-cell lymphoma 387
Activity of BKM120 and BEZ235 against lymphoma cells 369
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine 368
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 362
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 347
Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery 333
The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines 303
NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy 292
Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma 289
Genomic profiling of enzastaurin-treated B cell lymphoma RL cells 287
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases 284
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 277
Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts 275
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 268
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 253
Molecular targeting of the PKC-β inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression 252
Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia 239
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination 233
The therapeutic strategy of HDAC6 inhibitors in lymphoproliferative disease 222
Totale 5.640
Categoria #
all - tutte 19.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.189


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 0 36
2021/2022462 31 28 55 24 9 50 27 20 42 36 84 56
2022/2023514 65 90 37 53 36 77 7 51 59 2 17 20
2023/2024259 10 16 11 33 57 18 27 35 3 5 20 24
2024/2025771 30 3 22 68 159 128 55 37 61 30 63 115
2025/20261.521 105 53 105 144 224 123 221 79 170 158 117 22
Totale 5.640